Alterations and hypermethylation of the p14(ARF) gene in gastric cancer
Related Experiment Video
Updated: Oct 15, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
S Iida1, Y Akiyama, T Nakajima
1Second Department of Surgery, Tokyo Medical and Dental University School of Medicine, Tokyo, Japan.
Abstract:
p14(ARF), generated through an alternative splicing process that replaces the first exon, 1alpha, of p16(INK4a) with exon 1beta, located >15 kb upstream of exon 1alpha, has been shown to function as a growth suppressor. We examined 11 gastric cancer cell lines for mRNA expression, homozygous deletion, mutation, and promoter methylation of the p14(ARF) gene. No mRNA expression was detected in 5 of the 7 diffuse-type cell lines. All intestinal cell lines displayed normal levels of expression except for one with a low level of expression. Of the 5 cell lines without expression, 3 (MKN45, NUGC-2, and NUGC-4) and 1 (KATO III) displayed homozygous deletion and methylation of the p14(ARF) gene, respectively. No mutation was found in the whole coding region of the p14(ARF) gene in 8 cell lines without homozygous deletion. Our results indicate that the p14(ARF) gene is more frequently inactivated by homozygous deletion or methylation in diffuse-type gastric cancer cell lines (5/7, 71.4%) than in intestinal ones (0/4, P = 0.022). When we also analyzed 62 primary gastric cancers for the methylation status of the p14(ARF) promoter region, the methylation frequency tended to be higher in diffuse-type gastric cancers (15/33, 45.5%) than in intestinal ones (7/28, 25%). Thus, p14(ARF) alterations might be involved in diffuse-type gastric carcinogenesis.
Insights
The p14(ARF) gene, a growth suppressor, is frequently inactivated in diffuse-type gastric cancer cell lines through homozygous deletion or methylation. This suggests p14(ARF) alterations play a role in diffuse-type gastric carcinogenesis.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The p14(ARF) gene, a product of alternative splicing from the p16(INK4a) locus, functions as a critical growth suppressor.
- Gastric cancer is a significant global health concern, with distinct subtypes like diffuse-type and intestinal-type.
Purpose of the Study:
- To investigate the alterations of the p14(ARF) gene in gastric cancer cell lines and primary tumors.
- To determine the frequency of p14(ARF) gene inactivation in diffuse-type versus intestinal-type gastric cancers.
Main Methods:
- Analysis of mRNA expression, homozygous deletion, mutation, and promoter methylation of the p14(ARF) gene in 11 gastric cancer cell lines.
- Examination of p14(ARF) promoter methylation status in 62 primary gastric cancer samples.
Main Results:
- No p14(ARF) mRNA expression was observed in 5 out of 7 diffuse-type gastric cancer cell lines.
- Homozygous deletion and promoter methylation were identified as mechanisms of p14(ARF) inactivation in diffuse-type cell lines.
- p14(ARF) inactivation was significantly more frequent in diffuse-type gastric cancer cell lines (71.4%) compared to intestinal-type (0%).
- Promoter methylation of p14(ARF) showed a higher frequency in primary diffuse-type gastric cancers (45.5%) than in intestinal-type (25%).
Conclusions:
- The p14(ARF) gene is frequently inactivated by homozygous deletion or methylation in diffuse-type gastric cancer.
- These findings suggest a potential role for p14(ARF) alterations in the development of diffuse-type gastric cancer.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
